Brief: Interpace Biosciences Q1 Revenue USD 10.273 Million
09/05/2024 21:01
May 09 (Reuters) - Interpace Biosciences Q1 net income USD 468 thousand. * Q1 operating income USD 874 thousand * Q1 operating expenses USD 5.197 million * Q1 gross profit USD 6.071 million
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million